Remedy Kombucha

The brand's defining production characteristic is a 30-day fermentation process, which the brand describes as long-aged brewing. This extended fermentation allows the live cultures to consume all residual sugar, resulting in a naturally sugar-free finished drink. Remedy positions this not as a technical workaround but as the core of its identity, distinguishing it from shorter-fermented competitors in the functional and fermented drinks category.

In 2018, Lion, a subsidiary of Japanese drinks conglomerate Kirin Holdings, acquired a minority stake in the business. That investment supported significant infrastructure growth: Remedy now operates an 18,000 square metre production facility in Melbourne's outer east, a considerable step from its warehouse beginnings. The range has expanded well beyond its original kombucha core to include live-cultured ginger beer, lemonade, and other fermented soft drink formats, with a Small Batch sub-range offering more adventurous flavour combinations.

Remedy is sold through multi-channel distribution: direct-to-consumer via the brand's own sites in both Australia and the UK, alongside mainstream supermarket and specialist retail listings. This international footprint reflects a deliberate expansion beyond the brand's Australian home market. Sober-curious drinkers and those seeking a flavourful, fermented alternative to conventional soft drinks make up the brand's core audience.